Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
about
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Introducing a new entity: chemotherapy-induced arrhythmia.Alternative Biomarkers for Combined Biology.Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma.Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
P2860
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Cardiac effects within 3 month ...... ous stem cell transplantation.
@en
Cardiac effects within 3 month ...... ous stem cell transplantation.
@nl
type
label
Cardiac effects within 3 month ...... ous stem cell transplantation.
@en
Cardiac effects within 3 month ...... ous stem cell transplantation.
@nl
prefLabel
Cardiac effects within 3 month ...... ous stem cell transplantation.
@en
Cardiac effects within 3 month ...... ous stem cell transplantation.
@nl
P2093
P2860
P1476
Cardiac effects within 3 month ...... ous stem cell transplantation.
@en
P2093
Ala-Kopsala M
Hartikainen J
Jantunen E
Kuittinen T
Nousiainen T
Vanninen E
Vuolteenaho O
P2860
P304
P356
10.1111/J.1600-0609.2006.00687.X
P577
2006-08-01T00:00:00Z